All In Biotech

Free tool

FAERS Monitor: Alvesco

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021658 or its brand name (Alvesco, Ciclesonide). Reports on generic versions are filed under their own applications.

Reports

11,143

Serious

10,133

91% of reports

Hospitalization

5,251

Death reported

567

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • asthma5,034
  • dyspnoea3,973
  • wheezing3,021
  • cough2,157
  • therapeutic product effect incomplete2,118
  • loss of personal independence in daily activities1,647
  • obstructive airways disorder1,440
  • pneumonia1,420
  • sleep disorder due to a general medical condition1,275
  • productive cough1,195
  • drug ineffective1,136
  • fatigue1,063
  • malaise1,012
  • chest discomfort908
  • nasopharyngitis898

Reports by year received

View as table
YearReports
20065
20078
200836
200971
2010114
2011179
2012201
2013208
2014225
2015293
2016443
2017413
2018600
2019951
20201,306
20211,966
2022893
20231,048
2024884
2025775
2026524

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,016 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
obstructive airways disorderSignal1,440280.6266.3349,207
sleep disorder due to a general medical conditionSignal1,275153.1145.1178,235
wheezingSignal3,021101.398.1285,338
asthmaSignal5,03487.986.1415,606
loss of personal independence in daily activitiesSignal1,64767.064.0103,553
therapeutic product effect incompleteSignal2,11857.955.7115,228
productive coughSignal1,19548.445.954,209
chest discomfortSignal90816.915.913,492
coughSignal2,15714.614.127,518
dyspnoeaSignal3,97313.313.046,242
nasopharyngitisSignal8989.28.76,612
pneumoniaSignal1,4208.37.99,227
malaiseSignal1,0124.44.12,670
fatigueSignal1,0632.62.41,064
drug ineffective1,1361.61.5292

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.